Economic burden of cardiovascular diseases in the enlarged European Union. - Wikidata - wikimedia - TriplyDB

Economic burden of cardiovascular diseases in the enlarged European Union.

Economic burden of cardiovascular diseases in the enlarged European Union.

http://www.wikidata.org/entity/Q50116064

about

Television viewing and incident cardiovascular disease: prospective associations and mediation analysis in the EPIC Norfolk Study Interventions to support return-to-work for patients with coronary heart disease Histone deacetylase signaling in cardioprotection Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease Myocardial Viability: From Proof of Concept to Clinical Practice.Non-invasive imaging of atherosclerosis Analysis and valuation of the health and climate change cobenefits of dietary change Multi-sensor fusion for enhanced contextual awareness of everyday activities with ubiquitous devices Health related quality of life assessment in acute coronary syndrome patients: the effectiveness of early phase I cardiac rehabilitation Productivity losses associated with cardiovascular disease: a systematic review.Regulation of Transcription Factors by Reactive Oxygen Species and Nitric Oxide in Vascular Physiology and Pathology.Advocacy for outpatient cardiac rehabilitation globally.In vivo functional photoacoustic microscopy of cutaneous microvasculature in human skin.Primary prevention of cardiovascular diseases: a cost study in family practices.Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data The effectiveness of German disease management programs (DMPs) in patients with type 2 diabetes mellitus and coronary heart disease: results from an observational longitudinal study.Healthcare costs associated with cardiovascular events in patients with hyperlipidemia or prior cardiovascular events: estimates from Swedish population-based register data.Calibration of an item bank for work capacity in cardiological rehabilitation patients.Medication taking in coronary artery disease: a systematic review and qualitative synthesis Community programs for the prevention of cardiovascular disease: a systematic review.A review of health utilities using the EQ-5D in studies of cardiovascular disease.A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities.The economic burden of self-reported and undiagnosed cardiovascular diseases and diabetes on Indonesian households.Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo).Development and pilot of an internationally standardized measure of cardiovascular risk management in European primary care.Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; a telephone survey.Barriers in access to healthcare services for chronic patients in times of austerity: an empirical approach in Greece.Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness study Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in Cost of disorders of the brain in Spain.Predictors of health-related quality of life in patients at risk for cardiovascular disease in European primary care.Cost-effectiveness of tailored print communication, telephone motivational interviewing, and a combination of the two: results of an economic evaluation alongside the Vitalum randomized controlled trial Low-density lipoprotein electronegativity is a novel cardiometabolic risk factor Genetics of mechanosensation in the heart.Effectiveness, safety and cost of drug substitution in hypertension Identifying factors associated with experiences of coronary heart disease patients receiving structured chronic care and counselling in European primary care.Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain.Economic valuation of informal care in cerebrovascular accident survivors in Spain.Secondary prevention in patients with coronary heart diseases: what factors are associated with health status in usual primary care?

P2860

Q21135375-E8639133-FC32-4866-AB53-842F51A25EC5 Q24198865-F40F77A4-43F2-4D2E-8DFD-BB97989B662E Q24568237-A4AB2C81-30A0-4B28-A0ED-F1BC90F20924 Q26739721-31074DB4-B873-4EB6-BD2D-79BFF60801FB Q26744602-C382535B-8B96-4975-A380-033DD7EF2225 Q26992143-CA62D302-E041-40C0-8A88-6047CBD3AA50 Q28005515-3B63DA62-A76B-4453-ACCA-6A60AF35F529 Q28236595-16D1F558-F7E3-4494-9FE3-40D911F70D8E Q28468599-99FE9C69-33B2-4DD0-B2C2-9D61C7A49FDC Q30241494-E746B984-D208-4DE4-9338-5F1E54DA0517 Q30275422-75AE0F25-25B4-4CD1-8446-DAFC8763BA8B Q30381867-5B2B1F30-3126-49AE-973C-191AFDCD7C45 Q30470721-017B440A-FCC1-49F1-B3D2-33BD880A4F5B Q30503671-FFDB2BF4-1108-41C2-90D1-6B07E8A93082 Q30599499-DE3C5BA7-7496-4D89-88E4-51E411768A48 Q30664819-5647C4B0-DA7D-4426-9B60-E94DA1F7F260 Q30972356-E2829B6D-5B18-4FD1-95D3-7100C76814E4 Q33454717-60FB299B-0017-431B-AB52-83C01F112B51 Q33599671-046D081D-9042-4901-BCF0-87A0BF97150E Q33644109-52CA99B3-599D-44D4-BAD5-FF1D4CE183FD Q33669647-263BE97A-17E1-4DA9-8AD9-7C62000673D2 Q33732066-CC2C245F-04C5-4A84-B027-144A18D07917 Q33734479-4F99EBF3-187A-4BD1-A1DD-CF6AB208EEFE Q33844762-D5E41FF0-5508-482F-AD0C-2ED12462D253 Q33865199-D0A858CA-DA9F-444A-B77C-93A6A622F3A2 Q33868965-10CC3206-208E-4709-94F5-B490F3C0AA43 Q33872893-AF943E91-89A8-4B30-B379-0E8295DB0798 Q33962766-7DBB1381-DFFA-41F6-A1DB-B2051CC3853E Q33992080-34B6676F-AB75-46A8-8645-0B1B08DE416E Q34016823-4F4E2130-BD94-4700-A982-9FF82FB85154 Q34062070-B5B232AE-6F6C-47A2-9C8E-FEC38F6465C3 Q34117492-CC1D9454-973D-475F-A81A-61BCF9933F50 Q34134154-AD15E744-CACF-4E42-9BFC-F9A2BAA75928 Q34156161-B82FFF47-E410-4B31-8B74-0B693FE23F59 Q34167579-706F1733-FE21-4A3D-96A8-FC0443CAB9A9 Q34174844-DA8100C2-E118-4554-AA7A-96783BDE168E Q34353957-830425FD-AA3B-4468-86FB-D287D189AB80 Q34413033-903CA06F-3049-4B7B-AAD1-482ED8BC95D7 Q34522286-554AAD07-421A-4C47-920A-BFD04F95D9BE Q34540227-6961E30E-5DB8-4666-A5DA-A67EEA65A3E2

P2860

Economic burden of cardiovascular diseases in the enlarged European Union.

http://www.wikidata.org/entity/Q50116064

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Economic burden of cardiovascular diseases in the enlarged European Union.

@en

Economic burden of cardiovascular diseases in the enlarged European Union.

@nl

type

label

Economic burden of cardiovascular diseases in the enlarged European Union.

@en

Economic burden of cardiovascular diseases in the enlarged European Union.

@nl

prefLabel

Economic burden of cardiovascular diseases in the enlarged European Union.

@en

Economic burden of cardiovascular diseases in the enlarged European Union.

@nl

P1433

Q50116064-77D94E5F-222B-4FD9-8DAF-A7ACBB8B6181

P1476

Q50116064-CE03B037-B62A-46CC-AC83-6D5D665A5574

P2093

Q50116064-064B2217-0309-43E1-8B09-BD4D487FCC79

Q50116064-0FC9DCC1-F86B-421F-B03E-97E82B074C15

Q50116064-0FF2E25E-14D4-4E6D-90E0-73770C025D1A

Q50116064-89D76E82-3935-4947-ADC2-FA894D278093

Q50116064-BD326891-2898-4F53-A9B4-0F542885607F

P2860

Q50116064-00F4F2FB-7849-4F98-A461-E0752BEC46A2

Q50116064-0F23BAC8-BBEF-4CC7-99C9-F2E56BAD509B

Q50116064-699BFB51-D27F-4B9A-8DE5-8C530A8FD766

Q50116064-82ECBB21-8C3C-4B73-8A8C-00673333E161

Q50116064-A9337275-C18E-47B4-8D69-7F1962A3A159

Q50116064-DEDA64C0-CD7F-473D-9C65-90479E4E8078

P304

Q50116064-23F02647-A6C4-41B1-9A43-A27646C5358D

P31

Q50116064-4D8C66EF-E2B4-409B-AC4B-77D4DD4536D4

P356

Q50116064-4A43A3F3-BEE2-4A38-9D67-20F5B7EC4611

P433

Q50116064-CB6DF25D-1C05-47DD-8372-1F434900C0B8

P478

Q50116064-7200F229-5001-4C33-9745-74498644E41D

P577

Q50116064-C2DDE9EF-DD2A-44A7-BFFF-71398A4C11BF

P5875

Q50116064-B7618609-0947-4DA2-A77A-DCE04F70CA1D

P698

Q50116064-48C128CF-CA39-41EB-A5C7-41788BF69146

P921

Q50116064-CFC77C38-FFE3-494B-964A-6F44E9F59C1E

P356

P1433

European Heart Journal

P1476

Economic burden of cardiovascular diseases in the enlarged European Union.

@en

P2093

Alastair Gray

http://www.w3.org/2001/XMLSchema#string

José Leal

http://www.w3.org/2001/XMLSchema#string

Mike Rayner

http://www.w3.org/2001/XMLSchema#string

Ramón Luengo-Fernández

http://www.w3.org/2001/XMLSchema#string

Sophie Petersen

http://www.w3.org/2001/XMLSchema#string

P2860

The economic burden of coronary heart disease in the UK.

Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS).

The relation between funding by the National Institutes of Health and the burden of disease.

The hospital cost of vertebral fractures in the EU: estimates using national datasets.

Does prevention of cardiovascular diseases lead to decreased cost of illness? Twenty years of experience from Finland.

Unit costs in international economic evaluations: resource costing of the Schizophrenia Outpatient Health Outcomes Study

P304

1610-1619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHI733

http://www.w3.org/2001/XMLSchema#string

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7282624

http://www.w3.org/2001/XMLSchema#string

P698

16495286

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease